PFSB Japan’s Second Committee Approves Nine New Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan PFSB’s Second Committee on Drugs agreed to the approval of nine new drugs, including domestically developed cell culture H5N1 influenza vaccines from both Kaketsuken and Kitasato Daiichi Sankyo.